Simone van Kralingen

Population Pharmacokinetics and Pharmacodynamics of Propofol in Morbidly Obese Patients

Simone van Kralingen, Jeroen Diepstraten, Mariska Y. M. Peeters et al. · Clinical Pharmacokinetics · 2011 · 78 citations

Obesity, Metabolic Syndrome, Medicine +5

Pharmacokinetics and protein binding of cefazolin in morbidly obese patients

Simone van Kralingen, Margot Taks, Jeroen Diepstraten et al. · European Journal of Clinical Pharmacology · 2011 · 72 citations

Obesity, Metabolic Syndrome, Pharmacology +4

Influence of Morbid Obesity on the Pharmacokinetics of Morphine, Morphine-3-Glucuronide, and Morphine-6-Glucuronide

Sjoerd de Hoogd, Pyry A. J. Välitalo, Albert Dahan et al. · Clinical Pharmacokinetics · 2017 · 52 citations · Full text

Obesity, Opioid Epidemic, Body Composition +8

Comparative evaluation of atracurium dosed on ideal body weight <i>vs.</i> total body weight in morbidly obese patients

Simone van Kralingen, E.M.W. van de Garde, Catherijne A. J. Knibbe et al. · British Journal of Clinical Pharmacology · 2010 · 33 citations · Full text

Comparative evaluation of propofol 350 and 200 mg for induction of anaesthesia in morbidly obese patients: a randomized double-blind pilot study

Simone van Kralingen, Jeroen Diepstraten, E.M.W. van de Garde et al. · European Journal of Anaesthesiology · 2010 · 22 citations